Albendazole in the treatment of pulmonary echinococcosis.
AUTOR(ES)
Aggarwal, P
RESUMO
Ten patients with pulmonary hydatid disease diagnosed on the basis of a chest radiograph and a positive response to the indirect haemagglutination test for hydatid disease were treated with albendazole 10 mg/kg/day for eight weeks. None of the 10 patients showed any radiological or serological improvement with this treatment regimen. Albendazole in these doses appears to have little role in the treatment of pulmonary hydatid disease.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=463292Documentos Relacionados
- Comparative evaluation of enzyme-linked immunosorbent assay for the diagnosis of pulmonary echinococcosis.
- Molecular and immunological diagnosis of echinococcosis.
- Hepatic tissue culture model for study of host-parasite interactions in alveolar echinococcosis.
- Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis.
- Albendazole treatment of pulmonary hydatid cysts in naturally infected sheep: a study with relevance to the treatment of hydatid cysts in man.
